Lion Posts First Profit for Bioinformatics Unit; No New Timeline for Delayed Sale | GenomeWeb

Lion Bioscience reported the first-ever profitable quarter for its bioinformatics business last week, but company officials were unable to provide an expected closing date for the sale of the unit, which was originally expected to wrap up before the end of the summer [BioInform 08-08-05].

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.